Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Demirkurek, H. C."" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł :
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.
Autorzy :
Beköz H; Division of Hematology, Department of Internal Medicine, Medical Faculty, Medipol University, Istanbul.
Karadurmuş N; Division of Medical Oncology, Department of Internal Medicine, Gulhane Research and Training Hospital, Ankara.
Paydaş S; Division of Medical Oncology, Department of Internal Medicine, Medical Faculty, Cukurova University, Adana.
Türker A; Division of Medical Oncology, Department of Internal Medicine, Medical Faculty, Hacettepe University, Ankara.
Toptaş T; Division of Hematology, Department of Internal Medicine, Medical Faculty, Marmara University, Istanbul.
Fıratlı Tuğlular T; Division of Hematology, Department of Internal Medicine, Medical Faculty, Marmara University, Istanbul.
Sönmez M; Division of Hematology,Department of Internal Medicine, Medical Faculty, Karadeniz Technical University, Trabzon.
Gülbaş Z; Division of Hematology, Anadolu Medical Center, Izmıt.
Tekgündüz E; Division of Hematology, Dr Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara.
Kaya AH; Division of Hematology, Dr Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara.
Özbalak M; Division of Internal Medicine, Bahçelievler State Hospital, İstanbul.
Taştemir N; Division of Hematology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul.
Kaynar L; Division of Hematology, Department of Internal Medicine, Medical Faculty, Erciyes University, Kayseri.
Yıldırım R; Division of Hematology, Department of Internal Medicine, Medical Faculty, Ataturk University, Erzurum.
Karadoğan I; Division of Hematology, Medstar Antalya Hospital, Antalya.
Arat M; Division of Hematology, Florence Nighthingale Hospital, Istanbul.
Pepedil Tanrıkulu F; Division of Hematology, Dr Turgut Noyan Research and Training Center, Baskent University, Adana.
Özkocaman V; Division of Hematology, Department of Internal Medicine, Medical Faculty, Uludag University, Bursa.
Abalı H; Division of Medical Oncology, Acıbadem University Medical Faculty Adana Hospital, Adana.
Turgut M; Division of Hematology, Department of Internal Medicine, Medical Faculty, Ondokuz Mayıs University, Samsun.
Kurt Yüksel M; Division of Hematology, Department of Internal Medicine, Medical Faculty, Ankara University, Ankara.
Özcan M; Division of Hematology, Department of Internal Medicine, Medical Faculty, Ankara University, Ankara.
Doğu MH; Division of Hematology, Istanbul Research and Training Hospital, Istanbul.
Kabukçu Hacıoğlu S; Division of Hematology, Department of Internal Medicine, Medical Faculty, Pamukkale University, Denizli.
Barışta I; Division of Medical Oncology, Department of Internal Medicine, Medical Faculty, Hacettepe University, Ankara.
Demirkaya M; Division of Medical Oncology, Department of Pediatrics, Medical Faculty, Uludag University, Bursa.
Köseoğlu FD; Division of Hematology, Department of Internal Medicine, Medical Faculty, Ege University, Izmir.
Toprak SK; Division of Hematology, Department of Internal Medicine, Medical Faculty, Ankara University, Ankara.
Yılmaz M; Division of Hematology, Department of Internal Medicine, Medical Faculty, Gaziantep University, Gaziantep.
Demirkürek HC; Division of Nuclear Medicine, V.K.V. American Hospital, Istanbul.
Demirkol O; Department of Nuclear Medicine, Koc University School of Medicine, İstanbul.
Ferhanoğlu B; Division of Hematology, V.K.V. American Hospital and Department of Internal Medicine, Division of Hematology, Koc University School of Medicine, Istanbul, Turkey. Electronic address: .
Pokaż więcej
Źródło :
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2017 Oct 01; Vol. 28 (10), pp. 2496-2502.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Antibodies, Monoclonal/*therapeutic use
Hodgkin Disease/*drug therapy
Adolescent ; Adult ; Aged ; Antineoplastic Agents/therapeutic use ; Brentuximab Vedotin ; Disease-Free Survival ; Female ; Hodgkin Disease/therapy ; Humans ; Immunoconjugates/therapeutic use ; Male ; Middle Aged ; Nivolumab ; Retrospective Studies ; Stem Cell Transplantation ; Young Adult
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies